<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">BACAMPICILLIN HYDROCHLORIDE</span><br/>(ba-kam-pi-sill'in)<br/><span class="topboxtradename">Penglobe <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Spectrobid<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">aminopenicillin</span><br/><b>Prototype: </b>Ampicillin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>400 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Acid-stable, penicillinase-sensitive aminopenicillin that is rapidly hydrolyzed to ampicillin in body. Has broad spectrum
         of antimicrobial activity and exerts antibacterial action by inhibiting bacterial cell wall synthesis. More rapidly and completely
         absorbed from GI tract than ampicillin is, and serum concentrations attained are higher.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Bacampicillin has a broad spectrum of antimicrobial activity against both gram-positive and gram-negative organisms.</p>
<h1><a name="uses">Uses</a></h1>
<p>Infections caused by susceptible microorganisms of upper and lower respiratory tract, urinary tract, skin and skin structures;
         acute uncomplicated gonorrhea.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to penicillins; pregnancy (category B); infectious mononucleosis or other viral diseases; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>History of allergy to cephalosporins; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Moderate to Severe Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 400800 mg q12h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 12.525 mg/kg q12h<br/><br/><span class="indicationtitle">Gonorrhea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1.6 g with 1 g probenecid times 1<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>
            				Note: Tablets may be given without regard to food.
            			
         </li>
<li>Do not give concurrently with disulfiram (Antabuse).</li>
<li>Store in tight container at 15°30° C (59°86° F) unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Hypersensitivity (erythematous rash; <span class="speceff-life">anaphylaxis</span>). <span class="typehead">GI:</span>
<span class="speceff-common">Nausea,</span> vomiting, anorexia, <span class="speceff-common">diarrhea</span>. <span class="typehead">Hematologic:</span> Thrombocytopenia, eosinophilia, anemia. <span class="typehead">Other:</span> Superinfections, fixed drug eruption. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>High urine bacampicillin concentrations can result in false-positive <span class="alt">urine glucose determinations with copper sulfate tests</span>
<i>(Benedict's, Clinitest, Fehling's);</i>
<span class="alt">glucose oxidase</span> methods <i>(Clinistix, TesTape)</i> are not affected. <span class="alt">Serum ALT</span> and <span class="alt">AST</span> may increase.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Allopurinol</b> increases incidence of rash; since ampicillin may interfere with <span class="classification">oral contraceptive</span> action, female patients should be advised to utilize nonhormonal contraception while on <span class="classification">antibiotics</span>. <span class="typehead">Food:</span> May decrease absorption of bacampicillin suspension; give 1 h before or 2 h after meals. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly and almost completely absorbed; hydrolyzed to ampicillin. <span class="typehead">Distribution:</span> Most body tissues; crosses placenta; appears in breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> 75% eliminated as ampicillin in urine within 8 h. <span class="typehead">Half-Life:</span> 0.71.1 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Determine previous hypersensitivity reactions to penicillins, cephalosporins, and other allergens prior to therapy.</li>
<li>Lab tests: Baseline C&amp;S tests prior to initiation of therapy; start drug pending results.</li>
<li>Baseline and periodic checks of renal, hepatic, and hematopoietic status are advised during prolonged therapy, particularly
            in patients with history of impaired function of these systems, and in premature infants and neonates.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report symptoms of an allergic hypersensitivity reaction immediately (see Appendix F).</li>
<li>Report signs of superinfection (see Appendix F).</li>
<li>Take all prescribed medicine as prescribed.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>